Target Market Determination (TMD) for the placement options offered under the Company's prospectus dated 29 December 2023
December 29, 2023December 29, 2023Alterity Therapeutics
Target Market Determination (TMD) for the placement options offered under the Company's prospectus dated 29 December 2023
Post navigation
Previous Post
Target Market Determination (TMD) for the free attaching SPP options offered under the Company's prospectus dated 29 December 2023
Related Posts
Prana Announces Successful Phase 2 Results in Huntington Disease Trial
February 18, 2014August 16, 2022
Further Information - Prana's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective
July 17, 2013August 16, 2022
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
August 15, 2023August 15, 2023
Leave a Reply Cancel reply
Your email address will not be published.Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Type in the text displayed above
Δ
Disclaimer
Alterity Therapeutics Ltd. published this content on 29 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 December 2023 03:41:42 UTC.